RxDoctor Payments Data

Michael Herrmann, MD

Obstetrics & Gynecology · Belleville, ILNPI 1164525093

Payments from drug & device makers

$4,423in general payments, 2019–2025

Across 239 payments — averaging $18.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Mayne Pharma Commercial LLC$697
  • Merck$332
  • Organon$223
  • Agile Therapeutics, Inc.$199
  • Myovant Sciences Inc.$186
  • plus $1K from 16 others

What the payments were for

  • Food & beverage$4,37399%
  • Education$501%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,423 in reported general payments places this provider in the 85th percentile of 1,732 obstetrics & gynecology providers in Illinois.

See all obstetrics & gynecology providers in Illinois

Medicare billing

Part B allowed, 2024
$7,479
Medicare patients
81
Services billed
120

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron14$12,115
Estradiol (Twice Weekly)Estradiol23$2,720
MimveyEstradiol/Norethindrone Acet11$2,140
Estradiol47$1,783
Raloxifene Hcl28$1,193
Clobetasol Propionate21$979
ValacyclovirValacyclovir Hcl14$603
Metronidazole21$599
Medroxyprogesterone Acetate20$442
Venlafaxine Hcl ErVenlafaxine Hcl29$375
Oxybutynin Chloride ErOxybutynin Chloride18$320
Bupropion Hcl SrBupropion Hcl11$284
Triamcinolone Acetonide46$248
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst14$206
Bupropion XlBupropion Hcl12$113

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$104$12,11514 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,732 obstetrics & gynecology providers in Illinois.

Other obstetrics & gynecology in Belleville

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →